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Abstract
It is well established that the intestinal microbiota plays a key role in the pathogenesis of Crohn’s disease (CD) and ulcerative
colitis (UC) collectively referred to as inflammatory bowel disease (IBD). Epidemiological studies have provided strong
evidence that IBD patients bear increased risk for the development of colorectal cancer (CRC). However, the impact of the
microbiota on the development of colitis-associated cancer (CAC) remains largely unknown. In this study, we established a
new model of CAC using azoxymethane (AOM)-exposed, conventionalized-Il10
2/2 mice and have explored the contribution
of the host intestinal microbiota and MyD88 signaling to the development of CAC. We show that 8/13 (62%) of AOM-Il10
2/2
mice developed colon tumors compared to only 3/15 (20%) of AOM- wild-type (WT) mice. Conventionalized AOM-Il10
2/2
mice developed spontaneous colitis and colorectal carcinomas while AOM-WT mice were colitis-free and developed only
rare adenomas. Importantly, tumor multiplicity directly correlated with the presence of colitis. Il10
2/2 mice mono-associated
with the mildly colitogenic bacterium Bacteroides vulgatus displayed significantly reduced colitis and colorectal tumor
multiplicity compared to Il10
2/2 mice. Germ-free AOM-treated Il10
2/2 mice showed normal colon histology and were
devoid of tumors. Il10
2/2; Myd88
2/2 mice treated with AOM displayed reduced expression of Il12p40 and Tnfa mRNA and
showed no signs of tumor development. We present the first direct demonstration that manipulation of the intestinal
microbiota alters the development of CAC. The TLR/MyD88 pathway is essential for microbiota-induced development of
CAC. Unlike findings obtained using the AOM/DSS model, we demonstrate that the severity of chronic colitis directly
correlates to colorectal tumor development and that bacterial-induced inflammation drives progression from adenoma to
invasive carcinoma.
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Introduction
The ability to mount an inflammatory response following injury
or exposure to foreign organisms is vital for host homeostasis and
survival. However, a persistently heightened immune response
such as that observed in chronic inflammatory disorders severely
impairs host organ function, ultimately resulting in disease [1]. A
major risk associated with chronic inflammation is increased
likelihood of cancer development [2–4]. Crohn’s disease (CD) and
ulcerative colitis (UC) collectively termed inflammatory bowel
disease (IBD) is the quintessential example in which chronic
inflammation translates to increased cancer risk [2]. The
cumulative incidence of colorectal cancer in IBD patients ranges
from 7.6% to 18.4%, 30 years post-diagnosis [5–8]. Furthermore,
epidemiological data suggest that the duration and severity of
chronic colitis represent significant risk factors for colitis-associated
colon cancer (CAC) [9–11]. Although the etiology of IBD remains
to be elucidated, animal model-based studies indicate that the host
intestinal microbiota triggers an immune response that is requisite
for the onset of disease [12–15]. This uncontrolled immune
response likely represents a defect in one or more immunosup-
pressive mechanisms intended to provide tolerance to the host
intestinal microbiota, resulting in the over-production of pro-
inflammatory mediators [12,16]
The concept of a balanced immunosuppressive response aimed
at regulating the microbiota may be best illustrated in interleukin-
10 knock-out (Il10
2/2) mice. These mice, which exhibit
intolerance to their intestinal microbiota develop spontaneous
colitis as the result of microbial-induced activation of effector T
cells [17–19].
The human colon harbor’s as many as 36,000 bacterial species
amounting to over 100 trillion aerobic and anaerobic bacteria
[20,21]. As a product of our co-evolution with bacteria, a
communication system has developed that allow us to regulate
one another, thereby maintaining intestinal homeostasis [21]. An
integral role in the cross-talk that occurs between the human
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e6026intestine and its resident microbiota is performed by innate
bacterial sensors known as pattern recognition receptors (PRRs)
[21]. Two main classes of PRRs have been shown to regulate
communication between the intestinal epithelium and the
microbiota. Toll-like receptors (TLRs) and Nod-like receptors
(NLRs) serve to alert the host to the presence of bacteria in the
extracellular and intracellular spaces respectively [22,23]. Using
the azoxymethane (AOM)/DSS model of CAC, Fukata and co-
workers showed that TLR4 participates in the development of
colorectal cancer [24]. Although interesting, this study has not
directly addressed the impact of the microbiota in CAC
development. Additionally, the AOM/DSS model of CAC
appears to show a dissociation between the severity of intestinal
inflammation and cancer development. Clearly, additional
investigation of the impact of bacteria on development of CAC
is needed.
In this study, we utilized germ-free and gnotobiotic technology
to modulate the content of the intestinal microbiota to determine
the direct impact of bacteria on the development of CAC. We
demonstrate that AOM-treated Il10
2/2 mice develop CAC in the
presence of colitogenic bacteria whereas germ-free mice remain
disease-free. The presence of colitis directly correlates with tumor
multiplicity and acts as a promoter of colorectal cancer.
Additionally, AOM-treated Il10
2/2; Myd88
2/2 mice failed to
develop colorectal tumors, indicating that bacterial signaling
through the TLR/MyD88 system is required for development of
CAC.
Results
Bacterial-mediated colitis enhances colorectal
tumorigenesis
To investigate the role of bacterial-mediated colitis in the onset
of colorectal carcinogenesis, conventionalized WT and Il10
2/2
mice were administered a regimen of AOM and monitored in vivo
for signs of colitis and tumor development by colonoscopy at
defined intervals (Fig. 1). After 16 weeks, WT mice showed no
evidence of macroscopic inflammation and displayed a semi-
translucent mucosa with well-defined vascularization associated
with a healthy colon (Fig. 2A, left panel). In contrast, Il10
2/2 mice
exhibited mucosal thickening and loss of apparent vasculature
associated with macroscopic intestinal inflammation (Fig. 2A,
middle panel). Macroscopic lesions compatible with tumors were
observed in conventionalized Il10
2/2 mice at week 16 (Fig. 2A,
right panel). To further study these lesions, histological analysis of
colonic tissues was performed on WT and Il10
2/2 mice. We
confirmed that the macroscopic lesions observed in Il10
2/2 mice
were tumors that developed in the inflamed colon. As shown in
Fig. 2B, AOM-treated Il10
2/2 mice showed a dramatic increase
in tumor penetrance and multiplicity compared to WT mice. In
our study, 8/13 (62%) of Il10
2/2 mice developed colon tumors
compared to only 3/15 (20%) of WT mice. Furthermore, tumor
multiplicity was 5-fold higher in Il10
2/2 mice with an average of
1- compared to only 0.2 tumors in WT mice (Fig. 2B) (p=0.034).
Of note, tumor development in Il10
2/2 mice was associated with
enhanced intestinal inflammation as determined by histological
analysis (Fig. 2C) (p,0.0001). Colonic expression of IL12p40 and
TNFa mRNA were significantly elevated in Il10
2/2- compared to
WT mice (Fig. 2C).
To further investigate the link between bacterial-induced colitis
and development of tumors, we performed linear regression
analysis, comparing histological inflammation score against tumor
number. Pearson correlation analysis revealed a strong positive
correlation between inflammation and colon tumor development
(p=0.0028). These data suggest that chronic colitis enhances the
progression of early transformation events initiated by AOM,
perhaps through establishing a microenvironment more support-
ive of cellular proliferation.
Chronic colitis enhances AOM-induced colorectal tumor
progression
Considering the dramatic increase in susceptibility to colon
tumor development, we hypothesized that mice with chronic
colitis may also demonstrate heightened susceptibility to advanced
tumor progression. Histological evaluation was performed and
tumors were classified as either as low- or high-grade dysplasia or
as invasive carcinoma. Seven of eight (88%) of tumor bearing
AOM/Il10
2/2 mice developed high-grade or invasive carcinoma
while none of the 3 tumors observed in WT mice showed evidence
of advanced histological stage (Fig. 3A). Representative examples
of colon tumor histology observed in AOM-treated WT and
Il10
2/2 mice are shown in figure 3B. These data suggest that
chronic colitis not only predisposes to increased susceptibility to
AOM-induced colorectal tumor development but also enhances
the tumors oncogenic potential, thereby promoting progression to
more advanced stages.
NFkB activity and cellular proliferation in tumors from
Il10
2/2 mice
NFkB signaling plays a critical role in promoting bacterial-
induced colitis in Il10
2/2 mice [25,26]. To verify the presence of
activated Rel A (NFkB)-signaling in the AOM/Il10
2/2 model of
CAC, we assessed the expression/localization of phosphorylated
RelA (S276) in Il10
2/2 colon tissues by immunohistochemistry
(IHC). Colons from Il10
2/2 mice showed abundant phosphory-
Figure 1. Experimental timeline for AOM-induced colitis-associated colon tumorigenesis and analysis. Germ free mice were transferred
to SPF conditions and allowed to acclimate for 5 weeks. Mice were given AOM injections once a week for 6 weeks (black arrowheads). Development
of colitis and tumor formation was monitored by colonoscopy from weeks 4 to 18 after transfer from germ free to SPF conditions (white arrowheads).
Mice were sacrificed between 18 and 20 weeks and tissues processed for histological and mRNA expression analysis.
doi:10.1371/journal.pone.0006026.g001
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more, the presence of numerous phosphorylated RelA positive
immune- and intestinal epithelial cells were observed in adenomas
from Il10
2/2 mice (Fig. 4B).
Due to its role in promoting cellular proliferation and survival,
we evaluated the distribution of Ki67 positive cells in actively
inflamed and neoplastic regions of colons isolated from AOM/
Il10
2/2 mice. Nuclear Ki67 staining was mostly restricted to the
crypt bases in WT mice (Fig. 5A). In contrast, the colonic mucosa
from inflamed Il10
2/2 mice showed areas of increased prolifer-
ation extending in some cases the full crypt length (Fig. 5A). In
addition, colorectal adenomas harvested from Il10
2/2 mice
Figure 2. Analysis of tumor induction and inflammation. A. Representative examples of WT (left panel) and Il10
2/2 colons (middle and right
panels) from AOM-treated mice 16 weeks after transfer to SPF conditions. B. Tumor penetrance and multiplicity in WT and Il10
2/2 mice (left and right
panels) (p=0.034). C. WT and Il10
2/2 colon inflammation scores, distal colon Il12p40 and Tnfa mRNA levels after 18–20 weeks under SPF conditions
(p=0.026).
doi:10.1371/journal.pone.0006026.g002
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mucosa (Fig. 5B). This enhanced proliferation is consistent with
increased accumulation of nuclear CTNNB1 in adenomatous
tissues from Il-10
2/2 mice (Fig. 5C). Taken together, these data
suggest that the heightened inflammatory and proliferative state
observed in the context of the Il10
2/2 mouse colon coupled with
AOM-induced activation of the WNT/CTNNB1 pathway results
in an increased propensity for colorectal tumor formation and
progression.
Germ free Il10
2/2 mice mono-associated with Bacteroides
vulgatus display reduced colitis and colon tumor
development compared to Il10
2/2 SPF mice
To further delineate the role of bacteria in promoting the
development of CAC, we mono-associated germ-free WT and
Il10
2/2 mice with Bacteroides vulgatus (B. vulgatus), an enteric
bacterium, which has been reported previously to induce only mild
colitis in the Il10
2/2 model of IBD [18]. Histological evaluation
showed that Il10
2/2 mice colonized with B. vulgatus developed
moderate colitis (average score=1.6) compared to WT mice
(average score=0.36) (Fig. 6A). These values however were
significantly less than inflammatory scores observed in conven-
tionalized Il10
2/2 mice (average score=2.6, p=0.03) (Fig. 6A).
Concordant with inflammation status, mono-associated Il10
2/2
mice displayed a significantly lower tumor multiplicity compared
to their conventionalized counterparts (0.4 and 2.3 respectively,
p=0.002) (Figure 6B). Pearson linear regression analysis revealed
a strong positive correlation between histological colitis score and
colorectal tumor number among B. vulgatus mono-associated mice
(p=0.009). Moreover, AOM-treated germ free Il10
2/2 mice
failed to develop colitis and consequently colorectal tumors as
confirmed by histological evaluation (Fig. 6A & B). These findings
indicate that the presence of colitogenic bacteria is essential for the
development of CAC.
MyD88 signaling is required for bacterial-induced CAC
To examine the role of TLR/MyD88 pathway signaling in
CAC development, Il10
2/2; Myd88
2/2 mice were administered
AOM and colorectal tumor formation was evaluated. Colonosco-
py showed the presence of neoplastic lesions in Il10
2/2 mice while
Il10
2/2; Myd88
2/2 mice showed no signs of disease (data not
shown). Representative examples of colon tissue histology for
Il10
2/2and Il10
2/2; Myd88
2/2 mice are shown in figure 7A.
Il10
2/2 mice developed an average of 0.8 colorectal tumors/
mouse while Il10
2/2; Myd88
2/2 mice were devoid of neoplastic
lesions (Figure 7B).
To explore the possibility that abrogated tumor formation in
Il10
2/2; Myd88
2/2 mice is the result of altered inflammatory-
cytokine expression, we used semi-quantitative PCR to determine
the relative mRNA expression levels of the pro-inflammatory
cytokines Tnfa and Il12p40 in the distal colon, the predominant
site of tumor formation. We observed significantly lower Il12p40
mRNA expression (p=0.032) as well as a notable trend toward
decreased Tnfa expression (p=0.089) in Il10
2/2; Myd88
2/2
compared to Il10
2/2 mice (Figure 7C). Altogether, these findings
indicate that bacterial-induced inflammation promotes the devel-
opment of colitis-associated colorectal cancer and is dependent on
TLR/MyD88 pathway signaling.
Discussion
Although UC represents the prototypical example of the link
existing between chronic inflammation and risk of developing
colorectal cancer, the mechanisms underlying this process remain
Figure 3. Il10
2/2 mice exhibit accelerated tumor progression. A.
Percent of tumor-bearing WT and Il10
2/2 mice with high-grade or
invasive carcinoma (upper panel). Representative low-grade adenoma
observed in WT mice (middle panel). Representative invasive carcinoma
observed in Il10
2/2 mice (lower panel).
doi:10.1371/journal.pone.0006026.g003
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experimental models, which make it difficult to recapitulate the
effects of chronic inflammation on colorectal tumorigenesis. In this
study, we showed that colitogenic bacteria are necessary for the
development of chronic intestinal inflammation leading to
tumorigenesis. Using AOM as a tumor initiator and the
microbiota to trigger chronic colitis in genetically susceptible
Il10
2/2 mice, we show that inflammation directly correlates with
colorectal tumor multiplicity and enhances tumor progression.
These events were not observed in Il10
2/2 mice housed under
germ-free conditions and were strongly attenuated in mice
associated with B. vulgatus, a weak inducer of intestinal inflamma-
tion. Furthermore, disruption of MyD88 signaling, a key
integrator of multiple TLRs prevented the development of
colorectal tumors in Il10
2/2 mice. These findings strongly
establish the microbiota as key in triggering intestinal inflamma-
tion and neoplastic changes in a susceptible host. The role of TLR
signaling in the development of colorectal cancer has been the
subject of recent intense investigation. Rakoff-Nahoum and co-
workers showed that MyD88 signaling contributes to tumor
progression in the Apc
Min model of human familial adenomatous
polyposis, suggesting a role for intestinal microorganisms in the
process of tumorigensis [27]. However, because cytokines such as
IL1 and IL18 also utilize MyD88 to activate downstream target
genes [28] the involvement of the intestinal microbiota in this
model is unclear. Moreover, the involvement of MyD88 signaling
in the development of CAC was not addressed in this study. A
better picture of the role of TLR signaling in CAC has begun to
emerge from studies using the AOM/DSS model. For example,
Fukata and coworkers demonstrated that colorectal tumorigenesis
Figure 4. Il10
2/2 mice develop inflammation displaying active Rel A (NFkB) signaling. A. Phosphorylated-Rel A immunostaining of normal
Il10
2/2 colon tissue. B. Enlargement of Rel A positive immune infiltrate in A. C. Phosphorylated Rel A immunostaining in Il10
2/2 adenoma. D.
Enlargement of adenoma in C. E. Rabbit IgG negative control.
doi:10.1371/journal.pone.0006026.g004
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2/2 mice, suggesting that this innate
receptor is important for the development of CAC [24]. However,
this strong reduction in neoplasia was not accompanied by a
concomitant reduction in inflammation. Consequently, there is an
apparent disconnect between intestinal inflammation and tumor-
igenesis in the AOM/DSS model. This phenomenon is not
specific to TLR signaling since a recent report showed that
tumorigenesis is dramatically reduced in Il6
2/2 and Stat3
2/2
mice, despite significantly higher inflammatory scores in these
mice [29]. In contrast, using the AOM/Il10
2/2 model, we
observed a strong correlation between inflammation score and
tumor multiplicity. This suggests that severe inflammation more
aptly supports the survival of early transformation events.
Additionally our data indicates that the presence of inflammation
irrespective of severity influences tumor progression. It is possible
that the tumor microenvironment present in the AOM/DSS
model differs from that in the AOM/Il10
2/2 model, which could
account for decreased tumorigenesis despite the high inflamma-
tory state in the former model.
Recent reports have provided insight into the role of colitis as a
promoter of colorectal tumorigenesis in the AOM/DSS model
[24,29]. However, one important question that remains unan-
swered is whether these tumor-promoting effects are elicited by the
wound-healing response inherently caused by DSS treatment or
by the inflammation that accompanies it. For example, Grivenni-
kov and co-workers demonstrate that Il6
2/2 mice exhibit
decreased tumor multiplicity and load compared to WT mice
after AOM/DSS treatment yet these mice displayed more severe
intestinal inflammation than WT mice. Consequently, reduced
tumorigenesis in this model is the result of impaired IL6/STAT3
Figure 5. Il10
2/2 normal colon and adenomas exhibit increased cell proliferation. A. Ki67 positive cells are restricted to crypt bases in
normal WT colon. Normal colons from Il10
2/2 mice exhibit elongated crypts with expanded Ki67 positive staining. B. Representative adenoma from
Il10
2/2 mouse shows increased Ki67 positive staining (left panel). Rabbit IgG negative control (right panel). C. Il10
2/2 adenoma shows positive
CTNNB1 staining.
doi:10.1371/journal.pone.0006026.g005
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intestinal inflammation. We demonstrate here that the AOM/
Il10
2/2 model of CAC can be used to investigate specifically, the
impact of colitis on colorectal tumorigenesis. Whether IL6/
STAT3 signaling is important in the development of CAC in
AOM/Il10
2/2 mice remains to be investigated. Additionally, we
show that CAC occurs in the context of activated NFkB pathway
signaling as shown by the presence of NFkB positive immune cells
suggesting that this inflammatory signaling pathway is important
in the development and/or promotion of neoplasia. Additional
studies will be required to more specifically define a role for NFkB-
mediated inflammatory signaling in CAC.
In summary, we show that the gut microbiota is essential to the
development of CAC and that chronic colitis promotes the
oncogenic potential of colorectal tumors resulting in progression to
advanced stages. These events are dependent on microbial
recognition by the TLR/MyD88 system. Modulation of this
important innate sensing system could represent a novel means by
which to prevent/attenuate development of CAC.
Materials and Methods
Ethics statement
All animal protocols were approved by the Institutional Animal
Care and Use Committee of the University of North Carolina at
Chapel Hill.
Mice and induction of CAC
WT and Il10
2/2 mice on the 129 SvEv background were bred
and housed in the Gnotobiotic Animal Facility at the University of
North Carolina at Chapel Hill. Ten to twelve week-old germ-free
mice were transferred to specific pathogen free (SPF) conditions
(conventionalized), and after 5 weeks were injected i.p. with
10 mg/kg body weight AOM (Sigma Aldrich) once a week for 6
weeks. Il10
2/2; Myd88
2/2 mice and control Il10
2/2 mice
(C57BL/6J/129) were raised under SPF conditions and at 12
weeks of age were injected with AOM as described above. All mice
tested free of helicobacter hepaticus and helicobacter pylori, two
known inducers of tumorigenesis in Il10
2/2 mice [30].
Bacterial colonization
Il10
2/2- and WT mice were mono-associated at 10–12 weeks
of age by gavage feeding and rectal swabbing with viable bacteria
cultured from guinea pig isolates of Bacteroides vulgatus. Mono-
associated mice were maintained in the Gnotobiotic Animal
Facility at the University of North Carolina at Chapel Hill.
Bacterial association and absence of contamination by other
bacterial species were confirmed by periodic aerobic culture of
stool samples and gram staining.
Necropsy and tumor histology
Upon sacrifice, colons were removed from the cecum to the
rectum, flushed with PBS, splayed longitudinally and tumors
counted. Distal colon tissue samples were collected and snap
frozen. Colons were swiss-rolled from the distal to the proximal
end, fixed overnight in 10% formalin and paraffin-embedded. Six
mm sections were prepared and stained with hematoxylin and
eosin for histologic analysis. Tumors were scored for inflammation
and tumor grade.
Histological evaluation of mucosal inflammation was performed
using a scoring system of 0 to 4 to classify the degree of lamina
propria mononuclear cell infiltration, crypt hyperplasia, goblet cell
depletion and architectural distortion, as previously described
[18]. Tumors were classified as low-grade dysplasia when they
displayed a disorganized epithelium lined by hyperchromatic cells
with nuclear pseudostratification. Tumors were classified as high-
grade when they contained back-to-back glands, high nuclear to
cytoplasmic ratios, increased nuclear pleomorphism and loss of
cellular polarity. Tumors were classified as invasive carcinomas
when there was clear penetration of the dysplastic region through
the muscularis mucosa resulting in desmoplastic response from the
neighboring stroma. Inflammation and neoplastic lesions were
scored by a trained pathologist.
Immunohistochemistry
Tissue sections were deparaffinized in xylene and rehydrated
through a graded series of alcohol washes. Immunohistochemistry
for phosphorylated-Rel A (RelA 276) was performed with a rabbit
polyclonal antibody diluted 1:50 (Cell Signaling Technology) using
the Vectastain Elite Rabbit IgG kit (Vector Laboratories). Ki67
immunohistochemisry was performed as follows: Endogenous
Figure 6. Modulation of microbiota-dependent colitis directly
affects tumor development. A. Comparison of inflammation scores
for Il10
2/2 mice under SPF, B. vulgatus mono-associated and germ free
conditions. B. Tumor multiplicity in Il10
2/2 mice under SPF, B. vulgatus
mono-associated and germ free conditions.
doi:10.1371/journal.pone.0006026.g006
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30 minutes. Antigen retrieval was carried out by boiling sections
for 7 minutes in 0.01 M citrate buffer pH 6.0 and cooled at room
temperature for 30 minutes. Blocking was performed with 3%
BSA in phosphate buffered saline (PBS) for 30 minutes at room
temperature. Ki67 monoclonoal antibody (Dako) was diluted
1:200. Biotinylated secondary antibody (Vector Laboratories) was
diluted 1:200 in 1% BSA/PBS. Subsequent steps were carried out
using the Vectastain ABC kit according to manufacturer
instructions. CTNNB1 immunohistohistochemistry was performed
using a mouse anti-CTNNB1 antibody diluted 1:100 (Transduc-
tion Laboratories) with the M.O.M. peroxidase kit (Vector
Laboratories). Primary antibody incubation steps were carried
out over-night at 4uC. Visualization was performed using 3,39-
diaminobenzidine (Dako).
Real-time PCR
RNA was isolated from distal colon tissues using the TRIzol
method (Invitrogen, Carlsbad, CA). cDNA was prepared by
reverse transcribing 1 mg RNA using 126 units of M-MLV reverse
transcriptase, 1 mM dNTPs and 875 pmol random primers
(Invitrogen). Semi-quantitative real-time PCR was performed
using an Eppendorf Realplex Master Cycler. PCR reaction:
150 nM final concentration of forward and reverse primers, 6 ml
of QuantiTect SYBR Green PCR Master Mix (Qiagen, Valencia,
CA) and 50 ng of cDNA template in a total of 12 ml. The
following PCR conditions were used: 95uC, 15 minutes; (95uC, 15
seconds; 56uC, 30 seconds; 72uC, 30 seconds)640 cycles.
Specificity and linearity of amplification for each primer set was
determined by melting curve analysis and calculation of the slope
from serial diluted samples. Relative fold-changes were deter-
mined using the DDCT calculation method. Values were
normalized to the internal control b-actin. Primers: Tnfa (59
ATGAGCACAGAAAGCATGATC 39and 59 TACAGGCT-
TGTCACTCGAATT 39) and Il12p40 (59 CACGGCAGCAGA-
ATAAATATG 39 and 59 TTGCATTGGACTTCGGTAGA 39).
Statistical analysis
Statistical analyses were performed using GraphPad Prism
version 5.0a. Comparisons made between WT and Il10
2/2 or
Il10
2/2 and Il10
2/2; Myd88
2/2 mice were analyzed using a
two-tailed unpaired t-test. Comparisons made between SPF, B.
vulgatus mono-associated and germ-free mice were analyzed using
a one-way analysis of variance (ANOVA). Individual compar-
isons were subsequently made using a two-tailed unpaired t-test.
Pearson correlation analysis was performed to assess correlation
between tumor number and inflammation severity in AOM-
treated WT and Il10
2/2 mice (n=22) using SAS (SAS Institute,
Cary NC).
Colonoscopy
Colonoscopy was performed 4, 8, 12, 16 and 18 weeks after
transfer of mice from germ-free to SPF conditions (Fig. 1) to follow
the progression of colitis and tumor formation. In vivo visualization
of tumors was performed using a ‘‘Coloview System’’ (Karl Storz
Veterinary Endoscopy). Mice were anesthetized using 1.5% to 2%
isoflurane and ,4 cm of the colon from the anal verge from the
splenic flecture was visualized. The procedures were digitally
recorded on an AIDA Compaq PC.
Figure 7. Il10
2/2; Myd88
2/2 mice show decreased tumor multiplicity and expression of Il12p40 and Tnfa mRNA. A. Representative
histology observed in Il10
2/2 and Il10
2/2; Myd88
2/2 mice treated with AOM. B. Tumor multiplicity in Il10
2/2 and Il10
2/2; Myd88
2/2 mice treated with
AOM. C. Relative expression of Il12p40 and Tnfa mRNA in the distal colons of Il10
2/2 and Il10
2/2; Myd88
2/2 mice.
doi:10.1371/journal.pone.0006026.g007
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